e-learning
resources
Munich 2014
Monday, 08.09.2014
Cystic fibrosis: basic science, physiology and clinical aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients
S. Su, T. Riccobene, C. Scott (Jersey City, United States Of America)
Source:
International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Session:
Cystic fibrosis: basic science, physiology and clinical aspects
Session type:
Poster Discussion
Number:
1975
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Su, T. Riccobene, C. Scott (Jersey City, United States Of America). Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients. Eur Respir J 2014; 44: Suppl. 58, 1975
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Lung clearance index predicts pulmonary exacerbations in cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Screening colonoscopy in adults with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Lung MRI findings in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Inflammatory biomarkers in urine of cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Lung Clearance Index (LCI) and FEV
1
on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Cystic fibrosis
Source: Eur Respir Mon; 2009: 45: 32–45
Year: 2009
Cystic fibrosis
Source: Annual Congress 2004 - Paediatric year in review
Year: 2004
Cystic fibrosis
Source: Eur Respir Mon; 2010: 47: 225–239
Year: 2010
Cystic fibrosis
Source: Eur Respir Monogr 2017; 77: 25-37
Year: 2017
Cystic fibrosis
Source: Eur Respir Monogr 2017; 77: 167-180
Year: 2017
Cystic fibrosis
Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I
Year: 2012
Cystic fibrosis
Source: Annual Congress 2013 –Paediatric Year in Review
Year: 2013
Cystic fibrosis
Source: ERS Course 2015
Year: 2015
Cystic fibrosis
Source: Eur Respir Monogr 2013; 62: 54-69
Year: 2013
Cystic fibrosis
Source: School Course 2014 - Pulmonary Rehabilitation
Year: 2014
Cystic fibrosis
Source: International Congress 2014 – Paediatric Year in Review
Year: 2014
Adaptation of
prevotella
during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept